Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 24, 2018

SELL
$7.8 - $13.69 $21.4 Million - $37.5 Million
-2,741,942 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$7.86 - $11.39 $6.02 Million - $8.72 Million
-765,958 Reduced 21.84%
2,741,942 $22.6 Million
Q2 2017

Aug 08, 2017

BUY
N/A
3,507,900
3,507,900 $57.7 Million

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.